These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26149967)

  • 21. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.
    Cheng D; Cao N; Chen J; Yu X; Shuai X
    Biomaterials; 2012 Feb; 33(4):1170-9. PubMed ID: 22061491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells.
    Radin D; Lippa A; Patel P; Leonardi D
    Biomed Pharmacother; 2016 Feb; 77():161-6. PubMed ID: 26796280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity.
    Song YF; Liu DZ; Cheng Y; Liu M; Ye WL; Zhang BL; Liu XY; Zhou SY
    Sci Rep; 2015 Nov; 5():16125. PubMed ID: 26530454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
    Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
    Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
    Ogawara K; Un K; Tanaka K; Higaki K; Kimura T
    J Control Release; 2009 Jan; 133(1):4-10. PubMed ID: 18840484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postexposure application of Fas receptor small-interfering RNA to suppress sulfur mustard-induced apoptosis in human airway epithelial cells: implication for a therapeutic approach.
    Keyser BM; Andres DK; Nealley E; Holmes WW; Benton B; Paradiso D; Appell A; Carpin C; Anderson DR; Smith WJ; Ray R
    J Pharmacol Exp Ther; 2013 Jan; 344(1):308-16. PubMed ID: 23129783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.
    Zoli W; Ulivi P; Tesei A; Fabbri F; Rosetti M; Maltoni R; Giunchi DC; Ricotti L; Brigliadori G; Vannini I; Amadori D
    Breast Cancer Res; 2005; 7(5):R681-9. PubMed ID: 16168113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the Sequential Actions of Doxorubicin and p53 on Tumor Cell Growth Via Branched Polyethylenimine-β-cyclodextrin Conjugates.
    Xie B; Peng J; Wang S; Zhang X; Nie H
    Ann Biomed Eng; 2016 Nov; 44(11):3372-3383. PubMed ID: 27122200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis.
    Kazemi A; Safa M; Shahbazi A
    Hematology; 2011 Jul; 16(4):225-31. PubMed ID: 21756539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC; López-Rivas A
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination effect of PectaSol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU-145 and LNCaP prostate cancer cell lines.
    Tehranian N; Sepehri H; Mehdipour P; Biramijamal F; Hossein-Nezhad A; Sarrafnejad A; Hajizadeh E
    Cell Biol Int; 2012 Jul; 36(7):601-10. PubMed ID: 22214228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways.
    Shyur LF; Lee SH; Chang ST; Lo CP; Kuo YH; Wang SY
    Phytomedicine; 2010 Dec; 18(1):16-24. PubMed ID: 20637573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.
    Xiao Y; Jaskula-Sztul R; Javadi A; Xu W; Eide J; Dammalapati A; Kunnimalaiyaan M; Chen H; Gong S
    Nanoscale; 2012 Nov; 4(22):7185-93. PubMed ID: 23070403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combined treatment TNF-alpha/doxorubicin alleviates the resistance of MCF-7/Adr cells to cytotoxic treatment.
    Cao W; Ma SL; Tang J; Shi J; Lu Y
    Biochim Biophys Acta; 2006 Feb; 1763(2):182-7. PubMed ID: 16483679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Codelivery of Doxorubicin and p53 Gene by β-Cyclodextrin-Based Supramolecular Nanoparticles Formed via Host-Guest Complexation and Electrostatic Interaction.
    Ooi YJ; Wen Y; Zhu J; Song X; Li J
    Biomacromolecules; 2024 May; 25(5):2980-2989. PubMed ID: 38587905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis.
    Joseph MM; Aravind SR; George SK; Raveendran Pillai K; Mini S; Sreelekha TT
    Eur J Pharm Biopharm; 2015 Jun; 93():183-95. PubMed ID: 25864443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells.
    Lee SJ; Hwang SO; Noh EJ; Kim DU; Nam M; Kim JH; Nam JH; Hoe KL
    Exp Mol Med; 2014 Feb; 46(2):e76. PubMed ID: 24525822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic p21 induced by p65 prevents doxorubicin-induced cell death in pancreatic carcinoma cell line.
    Zhou Y; Li G; Ji Y; Liu C; Zhu J; Lu Y
    J Biomed Sci; 2012 Feb; 19(1):15. PubMed ID: 22305266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.